NF-B in biology and targeted therapy: new insights and translational implications

NF-kappa B signaling has been discovered for nearly 40 years. Initially, NF-kappa B signaling was identified as a pivotal pathway in mediating inflammatory responses. However, with extensive and in-depth investigations, researchers have discovered that its role can be expanded to a variety of signaling mechanisms, biological processes, human diseases, and treatment options. In this review, we first scrutinize the research process of NF-kappa B signaling, and summarize the composition, activation, and regulatory mechanism of NF-kappa B signaling. We investigate the interaction of NF-kappa B signaling with other important pathways, including PI3K/AKT, MAPK, JAK-STAT, TGF-beta, Wnt, Notch, Hedgehog, and TLR signaling. The physiological and pathological states of NF-kappa B signaling, as well as its intricate involvement in inflammation, immune regulation, and tumor microenvironment, are also explicated. Additionally, we illustrate how NF-kappa B signaling is involved in a variety of human diseases, including cancers, inflammatory and autoimmune diseases, cardiovascular diseases, metabolic diseases, neurological diseases, and COVID-19. Further, we discuss the therapeutic approaches targeting NF-kappa B signaling, including IKK inhibitors, monoclonal antibodies, proteasome inhibitors, nuclear translocation inhibitors, DNA binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T. Finally, we provide an outlook for research in the field of NF-kappa B signaling. We hope to present a stereoscopic, comprehensive NF-kappa B signaling that will inform future research and clinical practice.